May 29, 2017 | Hong Kong-based investment group AID Partners has acquired Israeli diagnostics startup GeneSort for $23 million. Founded in 2013, GeneSort is led by Dr. Gil Pogozelich. The molecular diagnostics company is focused on integrating genomics with personalized therapeutic approaches.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments